Signaling by the JNK group of MAP kinases

被引:72
作者
Dong, C
Davis, RJ
Flavell, RA
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Howard Hughes Med Inst, New Haven, CT 06520 USA
[3] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA
[4] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA
关键词
c-Jun N-terminal kinase; T lymphocytes; T helper 1 (Th 1); Th2;
D O I
10.1023/A:1010975124110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
c-Jun N-terminal kinase (JNK) is one of the several main MAP kinase groups identified in mammals. Original studies by use of Jurkat T cells implicated JNK in T cell activation and interleukin (IL-2) expression. Recent advances using mouse genetic approaches have revealed novel functions of this pathway in primary mouse T cells. JNK is not essential for T-cell activation; instead, it is required for helper T differentiation into effector cells and their cytokine production. In this review, we summarize these advances in understanding the expression, function, and regulation of the JNK pathway in T-lymphocyte activation and differentiation.
引用
收藏
页码:253 / 257
页数:5
相关论文
共 30 条
[21]   Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2 [J].
Sabapathy, K ;
Jochum, W ;
Hochedlinger, K ;
Chang, LF ;
Karin, M ;
Wagner, EF .
MECHANISMS OF DEVELOPMENT, 1999, 89 (1-2) :115-124
[22]   c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation [J].
Sabapathy, K ;
Kallunki, T ;
David, JP ;
Graef, I ;
Karin, M ;
Wagner, EF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) :317-328
[23]   JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development [J].
Sabapathy, K ;
Hu, YL ;
Kallunki, T ;
Schreiber, M ;
David, JP ;
Jochum, W ;
Wagner, EF ;
Karin, M .
CURRENT BIOLOGY, 1999, 9 (03) :116-125
[24]   JNK IS INVOLVED IN SIGNAL INTEGRATION DURING COSTIMULATION OF T-LYMPHOCYTES [J].
SU, B ;
JACINTO, E ;
HIBI, M ;
KALLUNKI, T ;
KARIN, M ;
BEN-NERIAH, Y .
CELL, 1994, 77 (05) :727-736
[25]   SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development [J].
Swat, W ;
Fujikawa, K ;
Ganiatsas, S ;
Yang, D ;
Xavier, RJ ;
Harris, NL ;
Davidson, L ;
Ferrini, R ;
Davis, RJ ;
Labow, MA ;
Flavell, RA ;
Zon, LI ;
Alt, FW .
IMMUNITY, 1998, 8 (05) :625-634
[26]   Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase [J].
Tournier, C ;
Whitmarsh, AJ ;
Cavanagh, J ;
Barrett, T ;
Davis, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7337-7342
[27]   Regulation of c-Jun NH2-terminal kinase (Jnk) gene expression during T cell activation [J].
Weiss, L ;
Whitmarsh, AJ ;
Yang, DD ;
Rincón, M ;
Davis, RJ ;
Flavell, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :139-145
[28]   Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity [J].
Yang, D ;
Tournier, C ;
Wysk, M ;
Lu, HT ;
Xu, J ;
Davis, RJ ;
Flavell, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3004-3009
[29]   Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2 [J].
Yang, DD ;
Conze, D ;
Whitmarsh, AJ ;
Barrett, T ;
Davis, RJ ;
Rincón, M ;
Flavell, RA .
IMMUNITY, 1998, 9 (04) :575-585
[30]  
Zhang F, 1998, J IMMUNOL, V161, P6105